The National Alliance of State Pharmacy Associations (NASPA) and the College of Psychiatric and Neurologic Pharmacists (CPNP) convened a stakeholder group in 2016/2017 to develop policy recommendations related to pharmacist administration of medications. These recommendations address the role of pharmacists in the administration of medications (beyond vaccines). The group took a deeper dive look specifically at the administration of long-acting antipsychotic medications (LAIs) because of the opportunity to resolve some access issues that are specific to these important medications.
Below is the report from that stakeholder group along with other resources that relate to pharmacist administration of medications.
**NASPA Members, please log-in to see all of the members-only information that is available**
State Policy Recommendations for Pharmacist Administration of Medications
The full policy paper that resulted from the work of the above stakeholder group.
*Available for members only, please log-in*
Pharmacist Medication Administer Authority Map
Of note, some states may have passed laws after publication of this map. Interpretation of state laws and regulations is complicated. Nothing posted here should be considered legal advice. Contact your state board of pharmacy with questions about your state’s authority.
American Pharmacists Association (APhA) Report
APhA Stakeholder Conference Report: Injectable Medications
The American Pharmacists Association (APhA) also recently completed work related to medication administration. This report details discussions from the APhA Stakeholder Conference and includes practice-based issues relating to pharmacist administration of medications.